Log in to save to my catalogue

Four-Repeat Tauopathies: Current Management and Future Treatments

Four-Repeat Tauopathies: Current Management and Future Treatments

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7851277

Four-Repeat Tauopathies: Current Management and Future Treatments

About this item

Full title

Four-Repeat Tauopathies: Current Management and Future Treatments

Publisher

Cham: Springer International Publishing

Journal title

Neurotherapeutics, 2020-10, Vol.17 (4), p.1563-1581

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Four-repeat tauopathies are a neurodegenerative disease characterized by brain parenchymal accumulation of a specific isoform of the protein tau, which gives rise to a wide breadth of clinical syndromes encompassing diverse symptomatology, with the most common syndromes being progressive supranuclear palsy-Richardson’s and corticobasal syndrome. De...

Alternative Titles

Full title

Four-Repeat Tauopathies: Current Management and Future Treatments

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7851277

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7851277

Other Identifiers

ISSN

1933-7213,1878-7479

E-ISSN

1878-7479

DOI

10.1007/s13311-020-00888-5

How to access this item